tiprankstipranks
Trending News
More News >
Bicara Therapeutics Inc. (BCAX)
:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Technical Analysis

Compare
32 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Bicara Therapeutics Inc.’s (BCAX) Moving Averages Convergence Divergence (MACD) indicator is 0.44, suggesting Bicara Therapeutics Inc. is a Sell.
Bicara Therapeutics Inc.’s (BCAX) 20-Day exponential moving average is 13.51, while Bicara Therapeutics Inc.’s (BCAX) share price is $12.67, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 50-Day exponential moving average is 13.38, while Bicara Therapeutics Inc.’s (BCAX) share price is $12.67, making it a Sell.

Bicara Therapeutics Inc. (BCAX) Pivot Points

May 08, 2025, 09:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.07
13.41
13.71
14.05
14.35
14.69
14.99
Fibonacci
13.41
13.66
13.81
14.05
14.30
14.45
14.69
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bicara Therapeutics Inc. (BCAX) Moving Averages

May 08, 2025, 09:28 PM
Period
Simple
Exponential
MA5
14.05Sell
13.81Sell
MA10
14.56Sell
13.89Sell
MA20
12.98Sell
13.51Sell
MA50
13.09Sell
13.38Sell
MA100
13.85Sell
15.01Sell
MA200
Bicara Therapeutics Inc.’s (BCAX) 10-Day exponential moving average is 13.89, while Bicara Therapeutics Inc.’s (BCAX) share price is $12.67, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 100-Day exponential moving average is 15.01, while Bicara Therapeutics Inc.’s (BCAX) share price is $12.67, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) stock price is $12.67 and Bicara Therapeutics Inc.’s (BCAX) 50-day simple moving average is 13.09, creating a Sell signal.
Bicara Therapeutics Inc.’s (BCAX) stock price is $12.67 and Bicara Therapeutics Inc.’s (BCAX) 100-day simple moving average is 13.85, creating a Sell signal.

Bicara Therapeutics Inc. (BCAX) Technical Indicators

May 08, 2025, 09:28 PM
Name
Value
Implied Action
RSI (14)
45.60
Neutral
STOCH (9,6)
29.51
Neutral
STOCHRSI (14)
55.97
Neutral
MACD (12,26)
0.44
Sell
ADX (14)
16.30
Buy
Williams %R
-62.61
Buy
CCI (14)
8.11
Neutral
ATR (14)
1.41
-
Ultimate Oscillator
52.18
Neutral
ROC
10.66
Buy
Bicara Therapeutics Inc.’s (BCAX) Relative Strength Index (RSI) is 45.60, creating a Neutral signal.
Bicara Therapeutics Inc.’s (BCAX) Trend Strength Indicator (ADX) is 16.30, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) Commodity Channel Index (CCI) is 8.11, creating a Neutral signal.
Bicara Therapeutics Inc.’s (BCAX) Price Rate of Change (ROC) is 10.66, creating a Buy signal.

FAQ

Is BCAX a Buy, Hold, or Sell?
Based on BCAX’s technical indicators, BCAX is a Sell.
    What is BCAX’s RSI (14)?
    BCAX’s RSI (14) is 45.60, which suggests BCAX is a Neutral.
      What is BCAX’s MACD?
      BCAX’s MACD is 0.44, which suggests BCAX is a Sell.
        What is BCAX’s 5-day moving average?
        BCAX’s 5-day moving average is 14.05, which suggests BCAX is a Sell.
          What is BCAX’s 20-day moving average?
          BCAX 20-day moving average is 12.98, which suggests BCAX is a Sell.
            What is BCAX’s 50-day moving average?
            BCAX’s 50-day moving average is 13.09, which suggests BCAX is a Sell.
              What is BCAX’s 200-day moving average?
              Currently, no data Available
              What is BCAX’s Williams % R (14)?
              BCAX’s Williams % R (14) is -62.61, which suggests BCAX is a Buy.
                What is BCAX’s CCI (14)?
                BCAX’s CCI (14) is 8.11, which suggests BCAX is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis